Vaccination against shingles increased among adults age 50 and older in the U.S. during the COVID-19 pandemic, but not equally across all population groups. That’s the key finding from a new study[1] my colleagues and I published in the journal Vaccine.
Shingles[2] is caused by the reactivation of the varicella-zoster virus[3], the same virus that causes chickenpox. It leads to a painful rash and potentially serious...